• The opioid epidemic has prompted a re-evaluation of pain-management strategies, highlighting the importance of balancing effective treatment with abuse prevention
• Nutriband’s AVERSA(TM) Fentanyl represents a significant advancement in this domain
• The company’s strategic development of AVERSA Fentanyl follows a structured pharmaceutical lifecycle

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies this forward-thinking approach (https://ibn.fm/jhHMY).

The opioid epidemic has prompted a reevaluation of pain-management strategies, highlighting the importance of balancing effective treatment with abuse prevention. Traditional methods often involve limiting prescriptions, which can inadvertently hinder patients with legitimate needs. Innovative pharmaceutical developments aim to address this by incorporating abuse-deterrent technologies, thereby reducing the potential for misuse without compromising therapeutic efficacy.

Nutriband’s AVERSA Fentanyl represents a significant advancement in this domain (https://ibn.fm/1PVVN). By integrating aversive agents such as denatonium benzoate and capsaicin into the transdermal patch, the product is designed to deter abuse through alternative administration routes, such as chewing or injecting. This approach maintains the patch’s effectiveness for pain management while reducing its attractiveness for misuse.

The development of AVERSA follows a structured pharmaceutical lifecycle, beginning with feasibility studies to assess the integration of abuse-deterrent technology into existing fentanyl patch systems. Nutriband collaborated with Kindeva Drug Delivery, leveraging its U.S. Food and Drug Administration (“FDA”)-approved transdermal fentanyl patch system to incorporate the AVERSA technology. This partnership facilitated the adaptation of commercial manufacturing processes to accommodate the new formulation.

Following successful feasibility assessments, the focus shifted to scaling up manufacturing capabilities. Kindeva completed the validation of analytical methods required to handle the aversive agents on the commercial production line. This step was crucial in ensuring consistent quality and safety standards for the modified patch.

Concurrently, Nutriband prepared for the pivotal human abuse potential (“HAP”) clinical study, a phase 1 trial designed to evaluate the patch’s deterrent properties. This study is a critical component of the 505(b)(2) New Drug Application (“NDA”) pathway, which allows for a streamlined approval process by referencing existing data on approved drugs. Notably, this pathway requires only a single clinical trial, expediting the time to market (https://ibn.fm/oPpC1).

To support these endeavors, Nutriband secured an $8.4 million private placement, earmarked for the commercial development of AVERSA Fentanyl through to NDA filing (https://ibn.fm/GorhG). The company aims to submit the NDA to the FDA in the first quarter of 2025, positioning AVERSA Fentanyl as potentially the first abuse-deterrent transdermal opioid patch approved globally. The potential impact of AVERSA Fentanyl extends beyond regulatory milestones. Market analysis suggests that the product could achieve peak annual U.S. sales between $80 million and $200 million, reflecting the significant demand for safer opioid delivery systems.

Nutriband’s approach underscores the importance of innovation in addressing complex public health issues. By focusing on technological solutions that deter abuse while preserving access, the company exemplifies a balanced strategy in combating the opioid crisis. As AVERSA Fentanyl progresses through the development pipeline, it holds promise as a model for future pharmaceutical innovations aimed at mitigating drug abuse.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs, has gained further recognition for the company’s commitment to its evolving model of sustainable football investment
• A recent Wall Street Journal article focused on the dangers of trying to apply the American sports model to English soccer by acquiring trophy assets, a lesson that some U.S. owners have finally learned
• Brera has successfully applied its multi-club ownership (“MCO”) approach, using its understanding and respect of English soccer’s advancement opportunities to grow and enrich its portfolio clubs, as shown with Brera’s acquisition agreement for S.S. Juve Stabia S.r.l. (“The Second Team of Naples”)
• These initiatives point to the company’s commitment to growing its clubs and turning them into leading brands that can leave their mark on progressively higher sports stages

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, has emphasized its commitment to the evolving model of sustainable football investment, something it believes is integral to long-term value creation (https://ibn.fm/YaGK8).

A Wall Street Journal article, published on April 26, 2025, by Joshua Robinson, noted U.S.-led investments’ role in shaping football across the U.K. and Europe’s top-division clubs. Of note was Wrexham, owned by Hollywood stars Ryan Reynolds and Rob McElhenney. Wrexham was acquired as a mid-table, 5th division team and has since finished this season just one step away from the vaunted English Premier League. In addition, its valuation has ballooned to £150m, representing an over 7,400% increase since its acquisition (https://ibn.fm/CkMT7).

Brera’s S.S. Juve Stabia S.r.l. has striking similarities with Wrexham, having been acquired by Brera after being newly promoted from Serie C to Serie B, Italy’s second division. As of March 2025, the club had posted a 36.9% surge in squad value from €11.78 million to €16.13 million, the largest percentage gain in Serie B during the period. The extraordinary growth pointed to the club’s huge untapped potential, currently holding 5th place of 20 teams, Serie A playoffs qualification, and Brera’s value-creation strategy (https://ibn.fm/jtjHU).

Brera is the first publicly traded MCO group through its Nasdaq IPO and continues to make waves in the industry. By providing a differentiated structure that combines professional management practices with public market transparency and governance standards, the company has demonstrated that disciplined, progressively advancing strategies can thrive, even in the competitive, ever-changing world of global football (https://ibn.fm/KPZbM).

Brera made a move to acquire S.S. Juve Stabia S.r.l. following its promotion to Serie B, the 2nd division of Italian football. With its current performance, the club is already confirmed to make the playoffs to potentially get promoted to Serie A, which speaks to Brera’s ability to spot opportunity and capitalize on it. It also speaks to the company’s ambitions to scale the club’s operations and revenue streams, as evidenced by its move to grow its international presence with the live broadcast of two of its matches, one against Catanzaro and another against Brescia, live with color commentary in English, in the U.S., Canada, and the U.K. via Destination Calcio TV.

“Expanding Juve Stabia’s reach to international audiences is a core pillar of our strategy,” noted Brera’s Executive Chairman, Daniel McClory. “Growing our fan base in the U.S. and Canada and other key international markets not only builds brand equity but also aligns with the broader global trend toward the internationalization of media rights in football,” he added (https://ibn.fm/BxTxd).

Brera has prioritized international media visibility, matchday revenue growth, and community engagement as key levers for building sustainable, globally recognized football brands. The ability for U.S., Canadian and U.K. fans to follow Juve Stabia, live and in English, is an essential step toward deepening the club’s global connections and preparing it for future opportunities both on and off the pitch.

Brera remains bullish about S.S. Juve Stabia and its other portfolio clubs worldwide. The success of this specific club validates its approach. It confirms its commitment to creating shareholder value and industry-leading clubs shaping and leaving their mark on the international stage.

For company information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• SolarBank and CIM Group have announced a US$100 million financing deal for a portfolio of U.S. solar energy projects totaling 97 MW.
• The deal is structured as a preferred equity investment at the project level, preserving SolarBank’s share capital, with CIM receiving a 3% annual coupon and retaining full ownership of transferred investment tax credits.
• SolarBank expects to maintain majority ownership of the 21-project portfolio post-financing, supporting SolarBank’s shift toward becoming a long-term solar asset owner in the U.S.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced a US$100 million project-based financing with infrastructure investor CIM Group to fund a 97 MW portfolio of solar energy projects in the United States. The deal marks a significant step in SolarBank’s evolution from solar developer to long-term asset owner, offering equity-style exposure to U.S. renewable energy growth without issuing new shares (https://ibn.fm/J7XIZ).

The financing will be structured as a preferred equity investment by CIM into a newly formed entity, New HoldCo. That entity will operate as a joint venture between CIM and Abundant Solar Power (“ASP”), a wholly owned subsidiary of SolarBank.

The 97 MW portfolio includes 21 solar projects located across the U.S., all currently under development by ASP. The projects will be transferred to New HoldCo in stages, with CIM providing 20% of the purchase price at mechanical completion and the remaining 80% at substantial completion. This structure allows the company to raise capital at the project level while preserving shareholder value.

CIM’s preferred equity interest will come with a 3% annual coupon, payable semi-annually. In addition to the coupon, CIM will retain 100% of the revenue from the sale of investment tax credits (“ITCs”), which will be transferred under Section 6418 of the Internal Revenue Code to third-party buyers.

SolarBank will receive the remaining project-level cashflows after CIM’s distributions. In the event of a liquidation or casualty event, proceeds will be distributed in proportion to each party’s contributions.

The agreement also includes a future redemption mechanism. New HoldCo may redeem CIM’s equity interest starting 180 days after the fifth anniversary of the last project going into service. The redemption price would be the greater of fair market value or a defined multiple of invested capital. If SolarBank chooses not to exercise this option, CIM retains the right to force a redemption at the lower of those two metrics.

CIM Group, based in Los Angeles, has long invested in infrastructure and real estate aimed at community and environmental impact. “This transaction with SolarBank to grow its portfolio of solar projects underscores our ongoing commitment to the renewable energy sector and our focus on supporting innovative companies leading the energy transition across North America,” said Kyle Hatzes, Managing Director of Infrastructure and Impact Investments at CIM Group.

For SolarBank, the deal helps accelerate its long-term strategy to become a long-term solar asset owner and power producer. The company is currently managing a solar development pipeline exceeding 1 gigawatt, with approximately 25 MWp of solar and 60 MWh of storage under construction, and another 149 MWp in late-stage development.

“The financing is another major milestone in SolarBank’s plans to grow its status as an independent power producer. Assuming full funding, SolarBank will retain a majority ownership interest in what is expected to be 21 solar energy projects with a total capacity of 97 MW,” said Dr. Richard Lu, President and CEO of SolarBank. “The transaction has been structured such that SolarBank does not have to issue any new shares, as the financing is being completed at the project company level.”

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward looking information. Please refer to the press release entitled “US$100 Million Transformative, Project Financing Announced by SolarBank and CIM Group to Fund 97 MW of Renewable Energy Assets in the United States” for additional details on the statements, risks and assumptions.  There are several risks associated with the transaction and development of the projects. The development of any project is subject to receipt of interconnection approval, receipt of a community solar contract, required permits, the continued availability of third-party financing arrangements for the Company and the risks associated with the construction of a solar power project. In addition, governments may revise, reduce or eliminate incentives. The transaction is subject to the execution of definitive documentation. SolarBank will also need to secure the financing required to develop the projects to mechanical completion and substantial completion, as prior to such milestone none of the funding from the transaction will be available.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• Ucore currently owns an REE mining project and an advanced separation technology.
• Commercial demonstration of the company’s RapidSX(TM) technology is at the commissioning stage.
• Ucore plans several modern REE refineries in North America, with the first SMC slated to begin construction in Louisiana in 2023. This planned REE separation and rare earth oxide production plant is scheduled to process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.
• Through its strategic partnerships with Kingston Process Metallurgy Inc., Mech-Chem Associates Inc. and other supporting contractors and vendors, Ucore is developing a North American REE supply chain.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX(TM), for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated by China.

China currently controls about 80% of the world’s access to REE mining projects and over 90% of the world’s REE processing capabilities, and it produces about 95% of the goods containing REE components.

Ucore is working to scale Western supply needs by establishing REE separation and rare earth oxide (“REO”) production capabilities in cooperation with strategic upstream supply and downstream offtake partnerships. The company, along with its industry partners, aims to unlock access to Western REEs for current consumer, energy, manufacturing and military sectors.

By 2025, Ucore expects to commercially separate U.S.-friendly sources of REEs and supply OEMs with REOs required to produce rare earth permanent magnets (“REPMs”) – the essential component of electric motors and generators required to support the world’s transition to electrification and sustainable energy sources.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (“SMCs”) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (“HREE”) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects and Technology

RapidSX(TM) Demonstration Plant

The Kingston, Ontario, RapidSX(TM) Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

• The techno-economic advantages of the RapidSX technology platform
• The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
• The platform’s ability to operate for thousands of semi-continuous run-time hours
• Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials
• The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX(TM) Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (“SX”) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (“SMC”). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

The company has three initial U.S.-friendly feedstock agreements in place for the Louisiana complex, along with multiple developing offtake agreements. It received a C$16 million+ incentive package offer from Louisiana Economic Development to support construction of the SMC.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

For more information, visit the company’s website at https://ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

• Nutriband’s AVERSA(TM) technology is advancing toward commercialization as the first abuse-deterrent transdermal fentanyl patch
• Recent FDA regulatory changes underscore the urgent need for safer opioid delivery methods and responsible prescribing
• Strategic milestones with partner Kindeva and a strengthened global IP portfolio position Nutriband for long-term growth

A Market Demanding Safer Opioid Solutions

The opioid crisis remains a critical public health challenge in the U.S. and globally, prompting a series of new regulatory measures designed to improve safety and reduce misuse. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid painkiller offering patients safer alternatives to opioids. Additionally, opioid manufacturers are now required to include prepaid mail-back envelopes for safe disposal of unused medications, while enhanced boxed warnings on opioid labels further reinforce the dangers of misuse, addiction, and overdose.

These regulatory shifts reflect a growing emphasis on not only expanding non-opioid options but also improving the safety of existing opioid therapies, creating a compelling market opportunity for innovative technologies that deter abuse without compromising patient access.

Nutriband’s Unique Approach to Abuse-Deterrent Delivery

Nutriband (NASDAQ: NTRB) is at the forefront of this evolving landscape with its proprietary AVERSA(TM) technology, which embeds aversive agents into transdermal drug patches to deter misuse, diversion, and accidental exposure. The company’s lead product, AVERSA(TM) Fentanyl, combines Nutriband’s abuse-deterrent formulation with Kindeva Drug Delivery’s FDA-approved fentanyl patch, aiming to become the world’s first opioid pain patch with built-in abuse-deterrent properties.

According to Nutriband’s shareholder letter in April, AVERSA(TM) Fentanyl could achieve peak annual sales between $80 million and $200 million, with its next candidate, AVERSA(TM) Buprenorphine, targeting peak sales of $70 million to $130 million. Importantly, recent commercial cost analyses have confirmed the economic viability of integrating AVERSA(TM) into existing FDA-approved transdermal products, positioning NTRB to capture high-margin opportunities in a market desperate for safer pain management solutions.

Progress Toward Commercialization

In 2024, Nutriband made significant strides in scaling up its manufacturing processes and strengthening its supply chain infrastructure to meet FDA regulatory standards. A major milestone was achieved with Kindeva Drug Delivery formalizing an exclusive partnership, enabling NTRB to shift from feasibility to full-scale commercial development of AVERSA(TM). This collaboration not only validates the technology but also reduces dilution risks for shareholders, as highlighted by the company’s successful $8.4 million private placement in April 2024.

Looking ahead, Nutriband is preparing to enter pivotal Human Abuse Liability (“HAL”) clinical trials, a key step toward filing a New Drug Application (“NDA”) with the FDA. The company’s global intellectual property portfolio, now covering 46 countries including recent approvals in China and the U.S., further cements its leadership in abuse-deterrent transdermal drug delivery.

A Strategic Outlook for 2025 and Beyond

Nutriband’s ambitions for 2025 include advancing AVERSA(TM) Fentanyl through clinical trials, exploring international licensing opportunities, and expanding its commercial manufacturing collaborations. Notably, its Pocono Pharma subsidiary continues to generate strong revenue from contract manufacturing services, particularly through its growing partnership with KT Tape, the world leader in kinesiology tape.

As opioid safety regulations tighten and the demand for abuse-deterrent therapies increases, Nutriband is well-positioned to capitalize on these trends. With a unique technology platform, strategic alliances, and a robust IP foundation, the company stands out as a promising player addressing one of the pharmaceutical industry’s most urgent challenges.

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

• A growing number of golfers competing at the highest levels of senior professional golf are making the switch to Newton’s innovative equipment.
• The tech behind the shaft is key to its performance.
• The benefits of Newton Motion shafts are not exclusive to seasoned professionals.

Newton Golf Company (NASDAQ: NWTG) Motion shafts are garnering significant attention for the impressive performance benefits they offer, particularly among players on the Champions Tour. A recent Golf.com article praised the high-quality construction of these shafts and noted that a growing number of golfers competing at the highest levels of senior professional golf are making the switch to Newton’s innovative equipment (https://ibn.fm/jj5ki). This surge in popularity highlights Newton Golf’s commitment to pushing the boundaries of golf shaft technology, offering players a more consistent, powerful and reliable swing.

“If you’ve been paying attention to what’s in players’ bags on the Champions Tour lately, you’ve probably noticed something sneaky-good popping up more and more: Newton Motion shafts,” the article stated. “In a sea of ‘proprietary blends’ and ‘made for’ composites, Newton shafts aren’t just your average pieces of graphite.”

The article details why Newton Motion shafts are rapidly becoming the choice of discerning professional players. Many players on the Champions Tour, who typically possess smooth, controlled swing tempos, find the Motion shafts particularly beneficial. The shafts are designed to maximize energy transfer during the swing, resulting in longer, more accurate drives.

Noting that Newton shafts support smoother, more efficient swings and keep spin and launch “dialed in without needing max effort,” the article reported that a Newton shaft “provides results: stability through the transition, tight dispersion and efficient energy transfer. When you’ve spent most of your professional career playing by feel, that’s everything. Newton gives [players] stability and performance, without sacrificing feel or feedback.”

The tech behind the shaft is key to its performance, the article noted. “The Newton Motion features something they call ‘Progressive Loading.’ In plain English, it means the shaft flexes in a way that better matches your swing tempo and speed. Instead of a harsh kick or too much lag, the Motion gives you a super controlled load and release, so you can square the face consistently and start it where you’re looking. This ‘Elongated Bend Profile’ enhances clubhead speed by allowing the shaft to bend over a longer span,” the article explained.

Importantly, the article also noted that the benefits of Newton Motion shafts are not exclusive to seasoned professionals. Amateur golfers and club players who have transitioned to Newton shafts are reporting similar improvements in performance. Stories of golfers gaining as much as 16 yards in driving distance after switching to a Newton shaft were cited, underscoring that the company’s technology offers real, tangible advantages for golfers of all levels. Whether a golfer is striving for greater consistency off the tee or simply looking to enjoy the game with improved results, Newton’s innovation is proving to be a game-changer.

Newton Golf’s official website provides additional context to the technologies that are transforming the way golfers approach equipment selection (https://ibn.fm/woY5A). The Newton Motion Driver Shaft, one of the company’s flagship products, is engineered to provide optimal swing speed, enhanced control, and smoother feel — all while maintaining maximum distance potential. Made with premium carbon fiber materials and tested rigorously in real-world conditions, the Motion Driver Shaft offers superior durability and consistency.

Another user-centric aspect of Newton Golf’s approach is its simplified flex selection system. Instead of relying on confusing traditional flex labels like “regular” or “stiff,” Newton recommends shafts based on a golfer’s average driving distance. This makes it much easier for players to find the correct shaft that matches their swing characteristics without second-guessing technical specifications. In addition to helping players select the right equipment, Newton backs its products with a 30-day money-back guarantee and offers free shipping within the continental United States, further reinforcing its customer-first commitment.

As the Newton Motion shafts continue to make waves on the Champions Tour and among amateur players, Newton Golf is solidifying its place as one of the most exciting and innovative brands in golf equipment today. By focusing on delivering real, measurable benefits to players and pushing the limits of shaft technology, Newton Golf is not just participating in the conversation about golf innovation but leading it.

For more information, visit www.NewtonGolfCo.com.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG

• SolarBank plans to develop a 7.2 MW DC ground-mount solar project in upstate New York, part of a growing pipeline of SolarBank developments in the area.
• The project will operate under a community solar model, with customer acquisition managed by Solar Simplified, and is expected to power approximately 850 homes.
• In addition, the new development will participate in New York’s VDER rate program and may qualify for NYSERDA incentives.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., announced the development of a new 7.2 megawatt DC ground-mount solar project in upstate New York. The Glor Rd project, as it is known, adds to a string of solar installations that the company is developing across the region (https://ibn.fm/Z98Pf).

The project will operate under New York’s community solar framework, which allows residents and renters to subscribe to clean energy without installing solar panels on their own properties. Once online, the project is expected to provide electricity for approximately 850 homes.

The company has secured a lease for the project site and initiated its interconnection study, a key step in assessing how the project will connect to the local electric grid. Completion of the study will allow the company to move forward with permitting and financing.

The project is eligible for compensation under New York’s Value of Distributed Energy Resources (“VDER”) mechanism. The VDER rate compensates solar projects for the energy they supply to the grid. For Glor Rd, the projected average year-one compensation is $0.0971/kWh under Public Utility Commission case 15-E-0751.

In addition, SolarBank is targeting one-time incentives of up to $0.245 per watt DC through the NYSERDA NY-Sun Program. These state-level incentives are designed to support the upfront financing of solar projects and are a key part of New York’s broader renewable energy strategy.

Once operational, Glor Rd will feed power directly into the grid, with subscribed residents earning monthly credits on their electric bills. Solar Simplified, SolarBank’s customer acquisition and subscription partner, will handle outreach, enrollment, and ongoing subscriber management. This arrangement enables SolarBank to concentrate on project development while ensuring a reliable revenue stream from full project subscription.

The Glor Rd site is part of a broader expansion by SolarBank across upstate New York, where the company is developing a pipeline of solar assets totaling more than one gigawatt. This effort reflects both state policy momentum in support of clean energy and growing private-sector appetite for distributed solar generation.

The project announcement reinforces SolarBank’s activity in a state that has been aggressively pursuing renewable energy targets. With policies like VDER and NYSERDA incentives in place, upstate New York continues to offer fertile ground for clean energy developers seeking stable returns and long-term growth.

For more information, visit the company’s website at SolarBankCorp.com.

This report contains forward-looking information. Please refer to the press release entitled “7.2 MW Glor Rd Solar Project in Development by SolarBank in New York” for additional details on the statements, assumptions and risks.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

• ESGold has identified a large-scale geophysical anomaly in the southwest zone of its Montauban Project in Quebec, showing strong conductivity and magnetic signals typical of VMS (volcanogenic massive sulfide) systems.
• A new 3D geological model is being developed, integrating historical and modern geophysical data, and an expanded Ambient Noise Tomography (“ANT”) survey will help define the anomaly’s structure and depth.
• The company continues to advance toward near-term production while evaluating district-scale exploration potential and offers a relatively affordable way for investors to gain gold exposure compared to purchasing bullion at high prices.

ESGold (CSE: ESAU) (OTCQB: ESAUF), a fully permitted, pre-production resource company on a clear path to near-term gold and silver production, has reported the identification of a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec. According to a company press release, internal analysis of historical VTEM (Versatile Time Domain Electromagnetic) survey data and drill records has highlighted this area as a high-priority exploration target (https://ibn.fm/1esM9).

The zone, which has not yet been tested by drilling, displays a strong combination of electromagnetic conductivity and magnetic response, a dual signal often associated with buried, sulfide-rich VMS (volcanogenic massive sulfide) deposits. These types of systems are typically high in base and precious metals, including copper, zinc, and gold.

ESGold believes this southwest anomaly may be larger and more structurally complex than the historically mined zones to the northeast. It forms part of a reevaluation of the project’s long-term potential, as the company continues to move toward initial production through tailings reprocessing later this year.

Since the original VTEM survey was conducted in 2015, ESGold has increased its landholdings in the region to 255 claims, totaling over 13,000 hectares. The company says this expansion was strategically driven by earlier geophysical data indicating the presence of clustered VMS systems, rather than a single-deposit structure.

To refine its understanding of the anomaly, ESGold is finalizing a 3D geological model of the Montauban property. This model will incorporate multiple datasets:

• The 2015 VTEM and total magnetic intensity (“TMI”) survey
• More than 950 historic drillholes
• Over 18,000 assays for gold, silver, and zinc
• Structural interpretation from geologic and geophysical mapping
• New data from an ongoing Ambient Noise Tomography (“ANT”) survey

The ANT method, which uses passive seismic imaging, was originally designed to reach 400 meters but has now imaged beyond 800 meters—doubling expectations and significantly increasing the potential to outline a deeper mineralized system. The 3D results will guide the future planned expansion of survey coverage.

Looking ahead, the company plans to release the 3D model in May 2025, followed by additional ANT data analysis and an updated Preliminary Economic Assessment (“PEA”). The new PEA will reflect both current metal prices and potential near-surface mineralization not previously factored into the economic model.

In parallel, construction work continues on ESGold’s tailings reprocessing facility, with the goal of commencing production by the end of 2025. The reprocessing operation offers a shorter-term revenue path while the company evaluates broader exploration opportunities.

ESGold’s shares offer a relatively low-cost way to gain exposure to potential upside in the gold market, particularly at a time when gold prices remain high. While buying physical gold or ETFs can be capital intensive, small-cap explorers like ESGold may offer higher return prospects should drilling confirm a new mineralized zone. If the anomaly proves mineralized, it could reframe the Montauban asset from a legacy mine to a multi-zone exploration play in a region historically known for precious and base metals. Further updates are expected following the release of the 3D geological model and interpretation of the expanded ANT survey later this quarter.

“The southwest anomaly represents a technically interesting and previously untested zone at Montauban,” said ESGold President Brad Kitchen. He added that while the near-term focus remains on production, the expanded land position and evolving dataset “are beginning to reveal a much broader opportunity.”

“With a growing dataset, disciplined exploration approach, and a pathway to self-funded discovery, ESGold is well positioned to pursue both production and the longer-term potential of the Montauban system,” he said.

For more information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

NOTE: ESGold Corp. has been invited to present at the Metals Investor Forum, being held in Vancouver on May 9, addressing gold and silver mining in North America.
Visit https://ibn.fm/Cfyhq and https://ibn.fm/JnaOi for information.

In addition, those unable to attend directly can view a live stream (https://ibn.fm/1rmRc).

• INBS offers a patented, non-invasive testing solution positioned to disrupt a global drug screening market projected to reach $14.9 billion by 2030.
• The company is revenue-generating, with 148% year-over-year growth in FY 2024 and 450+ active customer accounts.
• Its Intelligent Fingerprinting system provides rapid, on-site results with a lower cost and higher convenience compared to traditional methods.
• The Intelligent Fingerprinting Drug Screening System is already in commercial use internationally, and a U.S. product launch is planned for 2025, with FDA 510(k) clearance in process and new patent protections underway.
• INBS is led by a seasoned executive team with global healthcare and commercialization experience.

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings such as opiates, cocaine, methamphetamine, and cannabis. This innovative approach positions INBS to transform drug testing protocols, particularly in industries where safety and speed are mission critical.

The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers companies and organizations to screen more efficiently. INBS continues to drive adoption in international markets, with customers spanning construction, logistics, healthcare, government, and drug treatment sectors.

INBS’s mission is centered on delivering accessible, transformative solutions that improve lives and operational safety. As the company expands toward a planned U.S. market launch in 2025, it is also strengthening its intellectual property portfolio and localizing solutions for Spanish-speaking regions.

The company is headquartered in New York, New York.

Intelligent Fingerprinting Drug Screening System

Intelligent Bio Solutions’ flagship offering is the Intelligent Fingerprinting Drug Screening System, a portable, three-part solution that includes a fingerprint collection cartridge, a lateral flow-based DSR-Plus reader, and software for rapid drug screening. Designed to be used on-site, this system eliminates the complexities and hazards of urine and saliva tests, offering a clean, fast, and non-invasive alternative.

The system screens for a broad range of substances including opiates, methamphetamine, cocaine, cannabis, benzodiazepines, and more. Its cost advantage is significant — point-of-care fingerprint tests cost approximately $20, compared to $300 for typical urine or saliva testing. The platform includes over 1,000 DSR-Plus Readers installed across customer sites, supporting a base of more than 450 active customer accounts globally. In clinical studies, the system demonstrated 94.1% accuracy and 100% specificity, providing a credible foundation for future FDA approvals and market expansion.

In addition to drug screening, INBS is developing a proprietary biosensor platform designed to detect specific biomarkers from non-invasive samples such as sweat, saliva, and interstitial fluid. These additional applications remain under development.

Market Opportunity

Intelligent Bio Solutions operates at the intersection of workplace safety, public health, and diagnostic innovation. The company is targeting the drug screening products market, which is projected to reach $14.9 billion by 2030, growing at a compound annual growth rate (“CAGR”) of 12.1%, according to Research and Markets.

In the U.S., substance abuse is a $400 billion issue, with more than 70% of individuals using illicit drugs or alcohol currently employed. This presents an urgent need for scalable, workplace-compatible screening technologies. Industries such as transportation, construction, mining, and healthcare are among the highest adopters of employee drug testing protocols, driven by regulatory requirements and safety imperatives.

INBS’s non-invasive solution is well-positioned to capitalize on trends toward less invasive, faster, and more convenient testing methods — potentially displacing legacy systems reliant on urine or saliva testing, which have longer turnaround times and greater administrative burdens.

Leadership Team

Harry Simeonidis, Chief Executive Officer, has over 25 years of experience across the healthcare, pharmaceutical, and life sciences industries. He previously served as General Manager for Surgery, Asia Pacific at GE Healthcare. Prior to that, he was President and CEO of GE Healthcare ANZ, where he led significant market share growth.

Spiro Sakiris, Chief Financial Officer, brings 34 years of expertise in accounting, taxation, IPO preparation, and capital raising. He is highly experienced with IFRS and U.S. GAAP applications in the life sciences sector and is a member of the Institute of Chartered Accountants of Australia & New Zealand.

For more information, visit the company’s website at https://ibs.inc.

NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

DGE invites experts, industry leaders, executives, and professionals of the life science industry to attend the Life Science Meeting Planners Summit, being held on May 15-16, 2025, in Philadelphia.

The event is hosted by Dynamic Global Events, a pioneer in organizing B2B events for the life science industry. The global event company caters to the dynamic information and networking needs of the pharmaceutical, biotechnology, healthcare, and medical device companies.

The Life Science Meeting Planners Summit offers cutting-edge insights into maximizing ROI, creating seamless event integrations, enhancing networking opportunities, and optimizing event design. Don’t miss this chance to connect with industry leaders and revolutionize your approach to life science meetings.

Why Attend?

• Stay updated on the latest meeting planning operations, regulations, and compliance for life science events
• Learn ways to overcome staff shortages, attract skilled talent, and plan events seamlessly
• Explore ways to incorporate digital tools and understand ROI for your event
• Discover ways to advance sustainability in event planning
• Connect with expert event planners, experienced third-party planners, and executives within the life science industry
• Strategize ways to gamify or personalize the event experience and explore the potential of integrating new technologies
• Create an interactive forum for remote attendees to increase engagement opportunities

Companies can schedule meetings with senior decision-makers and discuss business deals one-on-one. The event offers a robust networking forum and collaboration among the brightest industry minds gathering for this DGE event.

To learn more, please visit https://ibn.fm/KWClI.